Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-022233
Filing Date
2022-06-13
Accepted
2022-06-13 18:05:39
Documents
1
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4021
  Complete submission text file 0000899243-22-022233.txt   5365
Mailing Address C/O TRANSLATE BIO, INC. 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Wooster Richard (Reporting) CIK: 0001774790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40287 | Film No.: 221012851

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Issuer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)